Journal of Pharmaceutical Investigation

Papers
(The H4-Index of Journal of Pharmaceutical Investigation is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Microneedle for transdermal drug delivery: current trends and fabrication185
Nanomedicine-based commercial formulations: current developments and future prospects74
Drug delivery to the brain via the nasal route of administration: exploration of key targets and major consideration factors55
Characterization studies of novel series of cobalt (II), nickel (II) and copper (II) complexes: DNA binding and antibacterial activity53
Controlled release and targeted drug delivery with poly(lactic-co-glycolic acid) nanoparticles: reviewing two decades of research48
Fabrication of aerosol-based nanoparticles and their applications in biomedical fields40
Smart pH-responsive nanomedicines for disease therapy39
Recent trends of self-emulsifying drug delivery system for enhancing the oral bioavailability of poorly water-soluble drugs35
Nanomedicine-based antimicrobial peptide delivery for bacterial infections: recent advances and future prospects33
Development of clindamycin-loaded alginate/pectin/hyaluronic acid composite hydrogel film for the treatment of MRSA-infected wounds31
Multifunctional lipidic nanocarriers for effective therapy of glioblastoma: recent advances in stimuli-responsive, receptor and subcellular targeted approaches30
Recent progress in hydrophobic ion-pairing and lipid-based drug delivery systems for enhanced oral delivery of biopharmaceuticals28
Intestinal membrane transporter-mediated approaches to improve oral drug delivery27
Recent progress in cancer immunotherapy approaches based on nanoparticle delivery devices26
Recent advancements in lipid–mRNA nanoparticles as a treatment option for cancer immunotherapy25
Lipid-based nanoparticles for photosensitive drug delivery systems24
Nanoparticles of ZnO/Berberine complex contract COVID-19 and respiratory co-bacterial infection in addition to elimination of hydroxychloroquine toxicity22
Recent progress in drying technologies for improving the stability and delivery efficiency of biopharmaceuticals21
Pharmaceutical application and development of fixed-dose combination: dosage form review20
Development of oral aprepitant-loaded chitosan–polyethylene glycol-coated cyclodextrin nanocapsules: formulation, characterization, and pharmacokinetic evaluation19
Selenium nanostructure: Progress towards green synthesis and functionalization for biomedicine19
0.024267911911011